EUVIMEDEUVIMED entdecken
Crossref

Synaptic Density Reductions in MSA : A Potential Biomarker Identified Through [ 18 F ] SynVesT ‐1 PET Imaging

Jian Li, Daji Chen, Yongxiang Tang, Zhao Chen, Ming Zhou, Linlin Wan iD, Ling Xiao iD, You Fu, Zhiyou He, Zhichao Tang, Zhengqun Hu, Xinrong Yuan und 9 weitere

Annals of Neurology · 2025-05 · 97 (5) · 879-893

DOI: 10.1002/ana.27179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 19.01.2025. Verfasst von Jian Li und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, People's Republic of China. Hauptthemen laut MEDLINE: Multiple System Atrophy, Synapses, Positron Emission Tomography Computed Tomography, Brain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Central South University Research Programme of Advanced Interdisciplinary Study, National Natural Science Foundation of China, Science and Technology Innovation Program of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this study was to delineate synaptic density alterations in multiple system atrophy (MSA) and explore its potential role as a biomarker for MSA diagnosis and disease severity monitoring using [ 18 F]SynVesT‐1 positron emission tomography / computed tomography (PET CT).

Methods

In this prospective study, 60 patients with MSA (30 patients with MSA‐parkinsonian [MSA ‐P] subtype and 30 patients with MSA‐cerebellar [ MSA ‐C] subtype), 30 patients with Parkinson's disease ( PD ), and 30 age‐matched healthy controls ( HCs ) underwent [ 18 F ] SynVesT ‐1 PET / CT for synaptic density assessment. Visual, voxel, and volumetric region of interest ( VOI ) analyses were used to elucidate synaptic density patterns in the MSA brain and establish diagnostic criteria. The diagnostic performances of both visual and VOI ‐based diagnostics were evaluated using receiver operating characteristic (ROC) analysis. Spearman correlation analyses were conducted to investigate the relationship between brain synaptic density and disease severity Results Patients with MSA displayed extensive reductions in synaptic density throughout the brain, notably affecting both primary VOIs (the cerebellum and putamen) and secondary VOIs including the medulla oblongata, ventral tegmental area, and pons. Notably, patients with MSA‐C exhibited a remarkable decrease in cerebellar synaptic density, whereas patients with MSA‐P demonstrated significant synaptic loss within the posterior putamen. Compared with patients with PD, the patients with MSA show a more pronounced reduction in synaptic density in infratentorial brain regions. VOI‐based diagnosis significantly outperformed visual analysis in diagnosing and differentiating MSA and its subtypes. Synaptic density in primary and multiple secondary VOIs correlated significantly with motor scales in patients with MSA.

Interpretation

Our study identified widespread synaptic density reductions in MSA, particularly in the basal ganglia and infratentorial region, suggesting [ 18 F]SynVesT‐1 PET as a potential biomarker for diagnosing and evaluating the disease, and guiding synaptic restoration trials. ANN NEUROL 2025;97:879–893

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple System AtrophySynapsesPositron Emission Tomography Computed TomographyBrainHumansMaleFemaleMiddle AgedAgedBiomarkersProspective StudiesParkinson DiseaseFluorine RadioisotopesPyridinesPyrrolidines

Substanzen

BiomarkersSynVesT-1Fluorine RadioisotopesPyridinesPyrrolidines

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
  • Department of Neurology, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
  • Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, People's Republic of China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
  • Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, People's Republic of China.
  • Department of Radiology, Xiangya Hospital, Central South University, Changsha, People's Republic of China.

ORCID-Profile: Linlin Wan, Ling Xiao, Beisha Tang, Jifeng Guo, Hong Jiang, Shuo Hu

Förderung

  • Central South University Research Programme of Advanced Interdisciplinary Study
  • National Natural Science Foundation of China
  • Science and Technology Innovation Program of Hunan Province
  • National Key R&D Program of China
  • Natural Science Foundation of Hunan Province
  • Key Program of Ministry of Industry and Information Technology of China
  • Clinical Research Foundation of the National Clinical Research Center for Geriatric Diseases (XIANGYA)
  • National Key Research and Development Program of China

Zitieren

APA

Li, J., Chen, D., Tang, Y., Chen, Z., Zhou, M., Wan, L., Xiao, L., Fu, Y., He, Z., Tang, Z., Hu, Z., Yuan, X., Yang, J., Zhu, S., Guo, X., Ouyang, R., Qiu, R., Tang, B., Guo, J., …, & Hu, S. (2025). Synaptic Density Reductions in MSA : A Potential Biomarker Identified Through [ 18 F ] SynVesT ‐1 PET Imaging. Annals of Neurology, 97(5), 879-893. https://doi.org/10.1002/ana.27179

Vancouver

Li J, Chen D, Tang Y, Chen Z, Zhou M, Wan L, et al. Synaptic Density Reductions in MSA : A Potential Biomarker Identified Through [ 18 F ] SynVesT ‐1 PET Imaging. Annals of Neurology. 2025;97(5):879-893. doi:10.1002/ana.27179

BibTeX
@article{Li2025,
  author = {Li, Jian and Chen, Daji and Tang, Yongxiang and Chen, Zhao and Zhou, Ming and Wan, Linlin and Xiao, Ling and Fu, You and He, Zhiyou and Tang, Zhichao and Hu, Zhengqun and Yuan, Xinrong and Yang, Jinhui and Zhu, Sudan and Guo, Xuan and Ouyang, Riwei and Qiu, Rong and Tang, Beisha and Guo, Jifeng and Jiang, Hong and Hu, Shuo},
  title = {Synaptic Density Reductions in MSA : A Potential Biomarker Identified Through [ 18 F ] SynVesT ‐1 PET Imaging},
  journal = {Annals of Neurology},
  year = {2025},
  volume = {97},
  number = {5},
  pages = {879--893},
  doi = {10.1002/ana.27179}
}
Kostenlos starten →